Liminatus Pharma, Inc. (LIMN) Ownership
LIMN ownership summary
as of October 18, 2026- Institutions
- 1.4% of shares outstanding
- Insiders
- 27.18% of shares outstanding
- Shares outstanding
- 1.3M
- Float
- 1.0M shares available to trade
- Short interest
- 4.12% 45K shares short
- Days to cover
- 1.62 short interest down 24.2% vs prior month
- Institutions 1.41%
- Insiders 27.18%
- Other investors 71.41%
LIMN top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | XTX Topco Ltd | 0.33% | 222K | $674,391 | +221,839 (0.0%) | June 30, 2026 |
| 2 | Geode Capital Management, LLC | 0.21% | 138K | $420,791 | +20,635 (+17.5%) | June 30, 2026 |
| 3 | Citadel Advisors Llc | 0.08% | 56K | $170,511 | −621,429 (−91.7%) | June 30, 2026 |
| 4 | Vanguard Capital Management, LLC | 0.08% | 50K | $153,338 | — | June 30, 2026 |
| 5 | The Goldman Sachs Group Inc | 0.06% | 40K | $122,269 | +40,220 (0.0%) | June 30, 2026 |
| 6 | StoneX Group Inc | 0.04% | 26K | $79,216 | +26,058 (0.0%) | June 30, 2026 |
| 7 | Vanguard Fiduciary Trust Co | 0.03% | 23K | $69,871 | — | June 30, 2026 |
| 8 | State Street Corp | 0.03% | 19K | $57,760 | — | June 30, 2026 |
| 9 | UBS Group AG | 0.02% | 17K | $50,859 | −37,848 (−69.3%) | June 30, 2026 |
| 10 | JustInvest LLC | 0.02% | 13K | $39,970 | −21,558 (−62.1%) | June 30, 2026 |
| 11 | Tower Research Capital LLC | 0.01% | 7,093 | $21,563 | −474 (−6.3%) | June 30, 2026 |
| 12 | Barclays PLC | 0.01% | 4,290 | $13,042 | +4,290 (0.0%) | June 30, 2026 |
| 13 | BlackRock Inc | <0.01% | 313 | $952 | −12,941 (−97.6%) | June 30, 2026 |
| 14 | Cygnus Capital Advisors, LLC | 0.00% | — | — | −350,000 (−100.0%) | June 30, 2026 |
| 15 | Jane Street Group LLC | 0.00% | — | — | −71,318 (−100.0%) | June 30, 2026 |
| 16 | Citigroup Inc | 0.00% | — | — | −6,769 (−100.0%) | June 30, 2026 |
| 17 | Two Sigma Investments LLC | 0.00% | — | — | −35,284 (−100.0%) | March 31, 2026 |
| 18 | Virtu Financial LLC | 0.00% | — | — | −27,468 (−100.0%) | June 30, 2026 |
| 19 | TWO SIGMA SECURITIES, LLC | 0.00% | — | — | −22,039 (−100.0%) | June 30, 2026 |
| 20 | Bank of America Corp | 0.00% | — | — | −44 (−100.0%) | March 31, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 5 holders added 313K shares and 12 cut 1.2M.
LIMN top mutual fund and ETF holders
4 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Fidelity Nasdaq Composite Index | 2.96% | 40K | $120,697 | +39,703 (0.0%) | August 31, 2026 |
| 2 | Fidelity Extended Market Index | 0.18% | 2,409 | $7,323 | — | August 31, 2026 |
| 3 | Fidelity Total Market Index | 0.01% | 161 | $489 | −1 (−0.6%) | August 31, 2026 |
| 4 | Fidelity Series Total Market Index | 0.01% | 124 | $377 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
LIMN shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns LIMN
Institutional investors own 1.4% of Liminatus Pharma's shares and insiders 27.18%. The largest holder is XTX Topco Ltd with 0.33% of the shares (222K), as of June 30, 2026. Among the top 20 institutions, 5 added shares and 12 reduced their stake in the latest filings. Short interest is 4.12% of the float, or 1.62 days of average trading volume. The share count rose 225.2% since 2023.
Related: LIMN key metrics. See the LIMN stock overview for the latest quote and news.
LIMN ownership FAQ
Who owns the most Liminatus Pharma stock?
The largest shareholders of Liminatus Pharma are XTX Topco Ltd (0.33%), Geode Capital Management, LLC (0.21%), Citadel Advisors Llc (0.08%), Vanguard Capital Management, LLC (0.08%), The Goldman Sachs Group Inc (0.06%).
What percentage of Liminatus Pharma is owned by institutions?
Institutions hold 1.4% of Liminatus Pharma's shares outstanding; insiders hold 27.18%.
Which funds own Liminatus Pharma?
The largest fund holders of Liminatus Pharma are Fidelity Nasdaq Composite Index (2.96%), Fidelity Extended Market Index (0.18%), Fidelity Total Market Index (0.01%), Fidelity Series Total Market Index (0.01%).
What is Liminatus Pharma's short interest?
45K shares of Liminatus Pharma were sold short, 4.12% of the float; at the average daily volume it would take 1.62 days to cover.
How many shares of Liminatus Pharma are outstanding?
Liminatus Pharma has 1.3M shares outstanding, of which 1.0M are in the public float.